Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Sadoff

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Bioconjugate Chemistry|November 1, 1990
Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodiesA K Bhattacharjee, J C Sadoff, H Collins, et al.
Genes and Immunity|April 13, 2007
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosisF F Weichold, S Mueller, C Kortsik, et al.
The Journal of Infectious Diseases|December 1, 1996
Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeysR Putnak, D A Barvir, J M Burrous, et al.
Vaccine|November 1, 1994
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneouslyR Edelman, D N Taylor, S S Wasserman, et al.
Infection and Immunity|October 1, 1981
Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosaP A Sokol, B H Iglewski, T A Hager, et al.
Critical Care Medicine|March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study GroupC L Sprung, L A Eidelman, R Pizov, et al.
Infection and Immunity|October 1, 1994
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccinesS C Szu, D N Taylor, A C Trofa, et al.
Infection and Immunity|October 1, 1988
Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoitesJ U Que, S J Cryz, R Ballou, et al.
The Journal of Clinical Investigation|September 1, 1991
Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsisS M Opal, A S Cross, J C Sadoff, et al.
Journal of Leukocyte Biology|January 1, 1993
Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensisR B Narayanan, J J Drabick, J C Williams, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Bioconjugate Chemistry|November 1, 1990
Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodiesA K Bhattacharjee, J C Sadoff, H Collins, et al.
Genes and Immunity|April 13, 2007
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosisF F Weichold, S Mueller, C Kortsik, et al.
The Journal of Infectious Diseases|December 1, 1996
Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeysR Putnak, D A Barvir, J M Burrous, et al.
Vaccine|November 1, 1994
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneouslyR Edelman, D N Taylor, S S Wasserman, et al.
Infection and Immunity|October 1, 1981
Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosaP A Sokol, B H Iglewski, T A Hager, et al.
Critical Care Medicine|March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study GroupC L Sprung, L A Eidelman, R Pizov, et al.
Infection and Immunity|October 1, 1994
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccinesS C Szu, D N Taylor, A C Trofa, et al.
Infection and Immunity|October 1, 1988
Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoitesJ U Que, S J Cryz, R Ballou, et al.
The Journal of Clinical Investigation|September 1, 1991
Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsisS M Opal, A S Cross, J C Sadoff, et al.
Journal of Leukocyte Biology|January 1, 1993
Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensisR B Narayanan, J J Drabick, J C Williams, et al.
Pageof 12